Supernus Pharmaceuticals (SUPN) Convertible Debt (2013 - 2022)
Supernus Pharmaceuticals (SUPN) posted quarterly Convertible Debt of $400.4 million for Q1 2022, up 9.38% year-over-year from $366.0 million in Q1 2021, and up 5.57% on a QoQ basis from $379.3 million in Q4 2021.
Supernus Pharmaceuticals (SUPN) Convertible Debt (2013 - 2022) Analysis & Trends
Supernus Pharmaceuticals has reported Convertible Debt for 10 years, with the latest figure at $400.4 million in Q1 2022.
- Convertible Debt for Q1 2022 came in at $400.4 million, up 9.38% year-over-year; the trailing twelve-month figure through Mar 2022 was $400.4 million (up 9.38% YoY), and the FY2021 annual result was $379.3 million, up 4.84% from the prior year.
- Convertible Debt advanced to $400.4 million in Q1 2022, from $379.3 million in the prior quarter.
- Over five years, Convertible Debt peaked at $400.4 million in Q1 2022 and troughed at $318.2 million in Q1 2018.
- A 5-year average of $350.7 million and a median of $347.2 million in 2019 frame the typical range for Convertible Debt.
- The widest annual swing landed in 2018, when Convertible Debt jumped 21769.57%; it then advanced 4.74% in 2019.
- A 5-year view of Convertible Debt shows it stood at $329.5 million in 2018, then rose by 4.77% to $345.2 million in 2019, then grew by 4.8% to $361.8 million in 2020, then advanced by 4.84% to $379.3 million in 2021, then grew by 5.57% to $400.4 million in 2022.
- Per Business Quant data, the three most recent Convertible Debt figures were $400.4 million in Q1 2022, $379.3 million in Q4 2021, and $374.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.76 Bn | 40.11 Bn | 2.15 Bn |
| 3 | Zoetis | 32.39 Bn | 30.71 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 400.38 Mn |
| Dec 31, 2021 | 379.25 Mn |
| Sep 30, 2021 | 374.79 Mn |
| Jun 30, 2021 | 370.38 Mn |
| Mar 31, 2021 | 366.04 Mn |
| Dec 31, 2020 | 361.75 Mn |
| Sep 30, 2020 | 357.52 Mn |
| Mar 31, 2020 | 349.23 Mn |
| Dec 31, 2019 | 345.17 Mn |
| Sep 30, 2019 | 341.16 Mn |
| Jun 30, 2019 | 337.21 Mn |
| Mar 31, 2019 | 333.31 Mn |
| Dec 31, 2018 | 329.46 Mn |
| Sep 30, 2018 | 325.67 Mn |
| Jun 30, 2018 | 321.92 Mn |
| Mar 31, 2018 | 318.23 Mn |
| Jun 30, 2017 | 1.47 Mn |
| Mar 31, 2017 | 3.31 Mn |
| Dec 31, 2016 | 4.17 Mn |
| Sep 30, 2016 | 5.77 Mn |